Thompson TC - Search Results

1

Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.

Tahir SA, Kurosaka S, Tanimoto R, Goltsov AA, Park S, Thompson TC. Tahir SA, et al. Among authors: thompson tc. Cancer Biol Ther. 2013 Feb;14(2):117-26. doi: 10.4161/cbt.22633. Epub 2012 Oct 31. Cancer Biol Ther. 2013. PMID: 23114714 Free PMC article.

2

Transforming growth factor beta 1 as a biomarker for prostate cancer.

Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. J Cell Biochem Suppl. 1992;16H:54-61. doi: 10.1002/jcb.240501212. J Cell Biochem Suppl. 1992. PMID: 1289674 Review.

3

Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.

Thompson TC, Egawa S, Kadmon D, Miller GJ, Timme TL, Scardino PT, Park SH. Thompson TC, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):79-85. doi: 10.1016/0960-0760(92)90190-t. J Steroid Biochem Mol Biol. 1992. PMID: 1525069

4

Experimental oncogene induced prostate cancer.

Thompson TC, Kadmon D, Timme TL, Merz VW, Egawa S, Krebs T, Scardino PT, Park SH. Thompson TC, et al. Cancer Surv. 1991;11:55-71. Cancer Surv. 1991. PMID: 1726789

5

Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.

Merz VW, Miller GJ, Krebs T, Timme TL, Kadmon D, Park SH, Egawa S, Scardino PT, Thompson TC. Merz VW, et al. Among authors: thompson tc. Mol Endocrinol. 1991 Apr;5(4):503-13. doi: 10.1210/mend-5-4-503. Mol Endocrinol. 1991. PMID: 1922083

6

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G. Thompson TC, et al. Oncogene. 1995 Mar 2;10(5):869-79. Oncogene. 1995. PMID: 7534899

7

Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.

Timme TL, Truong LD, Slawin KM, Kadmon D, Park SH, Thompson TC. Timme TL, et al. Among authors: thompson tc. Microsc Res Tech. 1995 Mar 1;30(4):333-41. doi: 10.1002/jemt.1070300408. Microsc Res Tech. 1995. PMID: 7541677 Review.

8

DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.

Greene DR, Taylor SR, Aihara M, Yoshida K, Egawa S, Park SH, Timme TL, Yang G, Scardino PT, Thompson TC. Greene DR, et al. Among authors: thompson tc. Int J Cancer. 1995 Jan 27;60(3):395-9. doi: 10.1002/ijc.2910600321. Int J Cancer. 1995. PMID: 7829250

9

Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.

Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, Park SH, Thompson TC. Timme TL, et al. Among authors: thompson tc. Endocrinology. 1994 Mar;134(3):1039-45. doi: 10.1210/endo.134.3.8119140. Endocrinology. 1994. PMID: 8119140

10

Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.

Slawin K, Kadmon D, Park SH, Scardino PT, Anzano M, Sporn MB, Thompson TC. Slawin K, et al. Among authors: thompson tc. Cancer Res. 1993 Oct 1;53(19):4461-5. Cancer Res. 1993. PMID: 8402613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters